Each point was worked out with the data available that day. Scale 0-10: 5 is the index average and 10 is the cap (+3 standard deviations), not perfection. The vertical axis zooms to fit this company, so two charts are not comparable by eye.
Market and Valuation
Price & Market
Prev Close Price:$66.53
Open:$66.12
Day's Low:$66.11
Day's High:$67.49
Bid / Ask:-
Market Cap:33.41B
Enterprise Value:24.99B
52-Week Range
52-Week Low:$31.63
52-Week High:$72.50
Current position in 52-week range
52w Low-52w High
50-Day Avg:$66.14
200-Day Avg:$55.45
Volume
Volume Today:4,719,357
Avg Volume (3m):4,508,796
Avg Volume (10d):5,569,890
52-Week Change:+84.24%
vs S&P 500, 52 weeks:-
Beta:1.08
Valuation Multiples
P/E (trailing):23.11
Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 27, 2026. The P/E is the price divided by that EPS.
P/E (forward):12.19
PEG Ratio:0.78
Price / Book:1.50
Price / Sales (TTM):0.19
EV / Revenue:0.14
EV / EBITDA:5.33
Dividends
Current yield:-
Annual Dividend Rate:-
Dividend Trailing:$0.00
Yield Trailing:0.00%
5-Year Avg Yield:-
Payout Ratio:0.00%
Last Ex-Dividend Date:-
Valuation Context
P/E vs sector (indicative)
Most Recent Quarter:-
Fiscal Year (Next):-
Loading historical OHLCV database...
Date
Open
High
Low
Close
Volume
Financial Statements TTM (Trailing 12 Months)
Income Statement
Total Revenue (TTM):180.41B
Gross Profit:20.46B
EBITDA:4.69B
Net Income (TTM):1.46B
Rev Growth (YoY):+0.20%
Earnings Growth (YoY):-
Quarterly earnings growth (YoY):-
Margins
Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-
Per Share
EPS Trailing (TTM):$2.92
Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 27, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$5.54
Revenue Per Share:$366.02
Cash Per Share:-
Book Value:$44.87
Last Dividend:-
Ex-Dividend Date:-
Last Split:-
Balance Sheet & Liquidity
Total cash:23.59B
Total Debt:15.54B
Net Debt (Debt - Cash):−8.04B (net cash)
Debt / Equity:69.67%
Current Ratio:1.16
Quick Ratio:1.12
Cash Flows
Operating Cash Flow:4.72B
Free Cash Flow (FCF):3.08B
FCF Yield (FCF / Market Cap):-
Enterprise Value:24.99B
EV / Revenue:0.14
EV / EBITDA:5.33
Profitability
ROE (Return on Equity):6.74%
ROA (Return on Assets):2.68%
P/E (trailing):23.11
P/E (forward):12.19
Price / Book:1.50
PEG Ratio:0.78
52-Week Change:+84.24%
S&P 500 change, 52 weeks:+11.37%
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
EPS Trailing (TTM):$2.92
Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 27, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$5.54
P/E (forward):12.19
PEG Ratio:0.78
Growth and Margins
Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-
Per Share
Revenue Per Share:$366.02
Cash Per Share:-
Book Value:$44.87
Cash Flows (TTM)
Free Cash Flow:3.08B
Operating Cash Flow:4.72B
EBITDA:4.69B
Total Revenue (TTM):180.41B
Net Income (TTM):1.46B
Fiscal Year (Last):-
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
Quarter
Period
Actual EPS
Estimated EPS
Difference
Surprise %
Currency
Ownership Structure
Ownership Distribution
% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float
Shares & Short Interest
Shares Outstanding:495,068,000
Float (free shares):464,745,085
Short interest (shares):10,934,979
Short % of float:-
Short Ratio (days to cover):2.30
Short interest, prior month:-
Short Interest Date:-
Governance Score (1=Best, 10=Worst)
Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
Organization
Report Date
% Shares
No. Shares
Value (USD)
Change %
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
Fund
Report Date
% Shares
No. Shares
Value (USD)
Change %
Recent Insider Trades
Executive / Insider
Title
Date
Action
Shares
Options Chain
CALLS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
PUTS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
Sentiment Metrics
Put/Call Ratio (Volume):-
Put/Call Ratio (O.I.):-
Max Pain (estimated):-
Total O.I. Calls:-
Total O.I. Puts:-
Expected move
Average IV (Calls ATM):-
Average IV (Puts ATM):-
Days to Expiration:-
Expected move (±):-
Centene Corporation (CNC) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.
No card. No spam.
Centene Corporation (CNC): Quantitative Analysis
Centene Corporation (CNC) — Healthcare — Healthcare Plans. CNC is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.
So far in 2026, CNC has returned +64.0% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.
CNC ranks 34 of 461 on today's multifactor score, and 3 of the 55 Healthcare companies that score. Its strongest factor is momentum (Z 1.54, ranked 33 of 494); its weakest is quality (Z -0.85, ranked 442 of 468). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.
Factor scores
The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.
Centene has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 12 after the close (SEC filings through Oct 26, 2026). CNC earnings dates and times, quarter by quarter →
What is Centene's P/E ratio?
Centene's P/E (price over earnings per share for the last twelve months) is 23.1 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Centene is below its sector median. Healthcare stocks, company by company →
Where does Centene rank on Quant500?
In the Nov 3, 2026 multi-factor ranking, Centene ranks 34 of 461, and 3 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking →How it is calculated →
Have Centene insiders bought or sold shares?
SEC Form 4 shows no open-market purchase of Centene shares from August 2025 through Nov 3, 2026. The latest sale was on Aug 26, 2026, by an officer, for $3.8M. In total, from August 2025 through Nov 3, 2026: 0 purchases and 5 sales by directors, officers and large shareholders. All CNC insider trades →
What sector is Centene in, and which index?
Centene is classified in the Healthcare sector (industry: Healthcare Plans), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →
What is behind these numbers
The concepts on this page, explained from scratch in the Academy. Free, no account.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
We save the portfolios you design, your own portfolio and your Academy progress, synced across devices.
Free, no card. Two automatic emails and no more: the one that confirms your address and the welcome one. After that, nothing you do not switch on yourself in your profile — such as the alert for insider buys, the same day they are reported to the SEC.